q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

2019 Medicare Part D Formulary Search By Drug Letter
This is archive material for research purposes. Please see PDPFinder.com or MAFinder.com for current plans.
Select a Letter below:
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
Links to Summaries by State for LTC Drugs on LIS/SNP Plans:
AK  AL  AR  AZ  CA  CO  CT  DC  DE  FL  GA  HI  IA  ID  IL  IN  KS  KY  LA  MA  MD  ME  MI  MN  MO  MS  MT  NC  ND  NE  NH  NJ  NM  NV  NY  OH  OK  OR  PA  PR  RI  SC  SD  TN  TX  UT  VA  VT  WA  WI  WV  WY

Drug Names Containing the Letter U in Alphabetical Order.
Example: Lipitor® is found on letter page "L" as well as letter page "A" for Atorvastatin.

Drug Name
 Packaging NDC On This Nbr of 2019 Formularies
PDPs MAPDs
ACTIGALL 300 MG CAPSULE
(Ursodiol)		 60 capsules   00023614501 2
PDPs		 8
MAPDs
ANORO ELLIPTA 62.5-25 MCG INH
(umeclidinium and vilanterol inhalation powder)		     00173086910 58
PDPs		 320
MAPDs
CARISOPRODOL-ASPIRIN-CODEIN TB
(Carisoprodol w/ Aspirin & Codeine)		 100.000 EA   64980017601 1
PDPs		 45
MAPDs
INCRUSE ELLIPTA 62.5 MCG INH
(Umeclidinium)		     00173087310 49
PDPs		 272
MAPDs
STELARA 45 MG/0.5 ML SYRINGE
(Ustekinumab)		 0.5ML   57894006003 17
PDPs		 165
MAPDs
STELARA 45 MG/0.5 ML VIAL
(Ustekinumab)		     57894006002 17
PDPs		 152
MAPDs
STELARA 90 MG/ML SYRINGE
(Ustekinumab)		 1ML   57894006103 17
PDPs		 165
MAPDs
TRAMADOL HCL ER 300 MG Tablet ER 24H [Ultram ER]
(TRAMADOL)		 30 tablets   68180069906 20
PDPs		 154
MAPDs
UCERIS 2 MG RECTAL FOAM FOAM/APPL
(Budesonide)		 66.8 grams   65649065103 2
PDPs		 144
MAPDs
UCERIS 9 MG ER TABLET
(budesonide)		     68012030930 0
PDPs		 21
MAPDs
UDENYCA 6 MG/0.6 ML SYRINGE
(Pegfilgrastim (E. coli))		 ml   70114010101 5
PDPs		 137
MAPDs
ULORIC TABLETS 40MG 30 BOT
(Febuxostat)		 30 BOT 64764091830 56
PDPs		 328
MAPDs
ULORIC TABLETS 80MG 30 BOT
(Febuxostat)		 30 BOT 64764067730 56
PDPs		 328
MAPDs
ULTRACET TABLET
(Tramadol-Acetaminophen)		 100.000 EA   50458065060 2
PDPs		 7
MAPDs
ULTRAM 50MG TABLETS
(Tramadol HCl)		 100 BOT 50458065960 2
PDPs		 7
MAPDs
ULTRAVATE 0.05 % 60 ML
(Halobetasol Propionate)		     10631012204 1
PDPs		 20
MAPDs
Ultravate 0.5mg/g 50 g in 1 TUBE
(Halobetasol Propionate)		 50 g in 1 TUBE   10631010250 2
PDPs		 7
MAPDs
Ultravate 0.5mg/g 50 g in 1 TUBE
(Halobetasol Propionate)		 50 g in 1 TUBE   10631010350 2
PDPs		 7
MAPDs
UNASYN 15GM VIAL
(Ampicillin & Sulbactam Sodium For)		 15 GM BOT 00049002428 0
PDPs		 4
MAPDs
UNASYN 3 GM VIAL
(Ampicillin, Sulbactam)		 mls   00049001481 1
PDPs		 5
MAPDs
UNITHROID 100 MCG TABLET
(Levothyroxine Sodium)		 100 EA   60846080501 59
PDPs		 297
MAPDs
UNITHROID 112 MCG TABLET
(Levothyroxine Sodium)		 100 EA   60846080601 60
PDPs		 297
MAPDs
UNITHROID 125 MCG TABLET
(Levothyroxine Sodium)		 100 EA   60846080701 59
PDPs		 297
MAPDs
UNITHROID 150 MCG TABLET
(Levothyroxine Sodium)		 100 EA   60846080901 59
PDPs		 292
MAPDs
UNITHROID 175 MCG TABLET
(Levothyroxine Sodium)		 100 EA   60846081001 59
PDPs		 297
MAPDs
UNITHROID 200 MCG TABLET
(Levothyroxine Sodium)		 100 EA   60846081101 59
PDPs		 297
MAPDs
UNITHROID 25 MCG TABLET
(Levothyroxine Sodium)		 100 EA   60846080101 59
PDPs		 297
MAPDs
UNITHROID 300 MCG TABLET
(Levothyroxine Sodium)		 100 EA   60846081201 59
PDPs		 297
MAPDs
UNITHROID 50 MCG TABLET
(Levothyroxine Sodium)		 100 EA   60846080201 59
PDPs		 297
MAPDs
UNITHROID 75 MCG TABLET
(Levothyroxine Sodium)		 100 EA   60846080301 59
PDPs		 297
MAPDs
UNITHROID 88 MCG TABLET
(Levothyroxine Sodium)		 100 EA   60846080401 59
PDPs		 292
MAPDs
UPTRAVI 1,000 MCG TABLET
(Selexipag)		     66215061006 33
PDPs		 247
MAPDs
UPTRAVI 1,200 MCG TABLET
(Selexipag)		     66215061206 33
PDPs		 247
MAPDs
UPTRAVI 1,400 MCG TABLET
(Selexipag)		     66215061406 33
PDPs		 247
MAPDs
UPTRAVI 1,600 MCG TABLET
(Selexipag)		     66215061606 33
PDPs		 247
MAPDs
UPTRAVI 200 MCG TABLET
(Selexipag)		     66215060214 33
PDPs		 247
MAPDs
UPTRAVI 200-800 TITRATION PACK
(Selexipag)		     66215062820 33
PDPs		 241
MAPDs
UPTRAVI 400 MCG TABLET
(Selexipag)		     66215060406 33
PDPs		 247
MAPDs
UPTRAVI 600 MCG TABLET
(Selexipag)		     66215060606 33
PDPs		 247
MAPDs
UPTRAVI 800 MCG TABLET
(Selexipag)		     66215060806 33
PDPs		 247
MAPDs
Urecholine 10mg/1 100 TABLET BOTTLE
(Bethanechol Chloride)		 100 TABLET BOTTLE   51285069002 0
PDPs		 4
MAPDs
Urecholine 25mg/1 100 TABLET BOTTLE
(Bethanechol Chloride)		 100 TABLET BOTTLE   51285069102 0
PDPs		 4
MAPDs
Urecholine 50mg/1 100 TABLET BOTTLE
(Bethanechol Chloride)		 100 TABLET BOTTLE   51285069202 0
PDPs		 4
MAPDs
Urecholine 5mg/1 100 TABLET BOTTLE
(Bethanechol Chloride)		 100 TABLET BOTTLE   51285069702 0
PDPs		 4
MAPDs
Urocit-K 10.000000meq/1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE
(Potassium Citrate)		 100 TABLET, EXTENDED RELE   00178061001 0
PDPs		 7
MAPDs
Urocit-k 15.000000meq/1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE
(Potassium Citrate)		 100 TABLET, EXTENDED RELE   00178061501 0
PDPs		 7
MAPDs
Urocit-K 5.0000000meq/1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE
(Potassium Citrate)		 100 TABLET, EXTENDED RELE   00178060001 0
PDPs		 7
MAPDs
UROXATRAL 10 MG TABLET
(Alfuzosin HCl)		     59212020010 0
PDPs		 4
MAPDs
Urso 250 250mg/1
(Ursodiol)		     58914078510 0
PDPs		 5
MAPDs
URSO FORTE TABLETS 500MG 100 BOT
(Ursodiol)		 100 BOT 58914079010 0
PDPs		 5
MAPDs
URSODIOL 250 MG TABLET
(Ursodiol)		 100.000 EA   49884041201 62
PDPs		 350
MAPDs
URSODIOL 300 MG CAPSULE
(Ursodiol)		     42806050301 57
PDPs		 321
MAPDs
URSODIOL 500 MG TABLET
(Ursodiol)		 100.000 EA   49884041301 62
PDPs		 348
MAPDs
UTIBRON NEOHALER 27.5-15.6 MCG CAP W/DEV
(Indacaterol and glycopyrrolate)		 60 units   63402068160 1
PDPs		 23
MAPDs
XURIDEN GRANULE PACKET
(Uridine Triacetate)		     69468015202 10
PDPs		 114
MAPDs



(Chart Source: Centers for Medicare and Medicaid files: CMS Data September 2019)




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs




© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.